Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation.

Pharmaceutics

School of Chemistry, University of Edinburgh, David Brewster Road, Edinburgh EH9 3FJ, UK.

Published: May 2017

High-pressure crystallisation has been successfully used as an alternative technique to prepare Form II of a non-steroidal anti-inflammatory drug, mefenamic acid (MA). A single crystal of Form II, denoted as high-pressure Form II, was grown at 0.3 GPa from an ethanolic solution by using a diamond anvil cell. A comparison of the crystal structures shows that the efficient packing of molecules in Form II was enabled by the structural flexibility of MA molecules. Compression studies performed on a single crystal of Form I resulted in a 14% decrease of unit cell volume up to 2.5 GPa. No phase transition was observed up to this pressure. A reconstructive phase transition is required to induce conformational changes in the structure, which was confirmed by the results of crystallisation at high pressure.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489933PMC
http://dx.doi.org/10.3390/pharmaceutics9020016DOI Listing

Publication Analysis

Top Keywords

mefenamic acid
8
single crystal
8
crystal form
8
phase transition
8
form
6
accessing mefenamic
4
acid form
4
form high-pressure
4
high-pressure recrystallisation
4
recrystallisation high-pressure
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!